Aconitum Napellus, Allium Cepa, Bryonia, Echinacea Angustifolia, Eupatorium Perfoliatum, Euphrasia Officinalis, Gelsemium Sempervirens, Pulsatilla, Rhus Tox
Generic Name: aconitum napellus, allium cepa, bryonia, echinacea angustifolia, eupatorium perfoliatum, euphrasia officinalis, gelsemium sempervirens, pulsatilla, rhus tox
Dosage form: POWDER. Active ingredients: ACONITUM NAPELLUS WHOLE (12 [hp_X]/kg); BRYONIA ALBA ROOT (9 [hp_X]/kg); ECHINACEA ANGUSTIFOLIA WHOLE (6 [hp_X]/kg); EUPATORIUM PERFOLIATUM FLOWERING TOP (6 [hp_X]/kg); EUPHRASIA STRICTA (6 [hp_X]/kg); GELSEMIUM SEMPERVIRENS ROOT (12 [hp_X]/kg); ONION (6 [hp_X]/kg); PULSATILLA VULGARIS WHOLE (9 [hp_X]/kg); TOXICODENDRON PUBESCENS LEAF (12 [hp_X]/kg). Category: DRUG FOR FURTHER PROCESSING.
Overview
Dosage form: POWDER. Active ingredients: ACONITUM NAPELLUS WHOLE (12 [hp_X]/kg); BRYONIA ALBA ROOT (9 [hp_X]/kg); ECHINACEA ANGUSTIFOLIA WHOLE (6 [hp_X]/kg); EUPATORIUM PERFOLIATUM FLOWERING TOP (6 [hp_X]/kg); EUPHRASIA STRICTA (6 [hp_X]/kg); GELSEMIUM SEMPERVIRENS ROOT (12 [hp_X]/kg); ONION (6 [hp_X]/kg); PULSATILLA VULGARIS WHOLE (9 [hp_X]/kg); TOXICODENDRON PUBESCENS LEAF (12 [hp_X]/kg). Category: DRUG FOR FURTHER PROCESSING.
Dosage
Available as powder.
Related Medications
Hydrocortisone Hemisuccinate
hydrocortisone hemisuccinate
Dosage form: POWDER. Active ingredients: HYDROCORTISONE HEMISUCCINATE (1 kg/kg). Category: BULK INGREDIENT.
Lidocaine And Capsaicin
lidocaine and capsaicin
Amide Local Anesthetic [EPC]
9. DESCRIPTION Trubrexa TM Transdermal Patch is comprised of an adhesive material containing 4.75% lidocaine and 0.025% capsaicin. Each patch is 2 in x 2 in (5.08 cm x 5.08 cm) and consists of an adhesive side containing the active/inactive ingredients and an outer surface backing layer with breathable fabric. The adhesive side is covered with a removable, clear, unprinted, plastic film. The outer surface of the backing layer is imprinted with the Trubrexa TM Transdermal Patch logo.
Dexrazoxane For Injection
dexrazoxane for injection
11 DESCRIPTION Dexrazoxane for injection, a cardioprotective agent for use in conjunction with doxorubicin, is a sterile, pyrogen-free lyophilizate intended for intravenous administration. Chemically, dexrazoxane is (S)-4,4'-(1-methyl-1,2-ethanediyl)bis-2,6-piperazinedione. The structural formula is as follows: C 11 H 16 N 4 O 4 M.W. 268.28 Dexrazoxane, an intracellular chelating agent, is a derivative of EDTA. Dexrazoxane is a whitish crystalline powder that melts at 191° to 197°C.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.